Delivery Order SPE2DB22D2211-SPE2DB25FSCPQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,561.56 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed-price contract. The delivery order was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and is classified as a non-set-aside competitive award. Performance will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of methylphenidate 5 mg chewable tablets (100-count bottles) with a contract ceiling value of $1,734.28. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units). This competitive, non-set-aside contract was awarded on September 25, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate 5 mg chewable tablets (100-count units) valued at $3,794.71 with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform fulfillment from its Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.43 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 2.5 mg chewable tablets (100-count units) with a contract value of $1,620.98. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, under a firm fixed-price delivery order structure. The contract was competitively awarded with no set-aside designation, and performance is based at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. This competitively awarded, non-set-aside contract is valued at $1,794.53 with a firm fixed price structure and an ultimate completion date of January 6, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a delivery order under its larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Methylphenidate 2.5 mg chewable tablets (100 count) with a ceiling value of $1,053.00. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCPQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,573.89 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units) under a firm fixed-price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, with no set-aside designation applied. Performance will be completed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical supplies to support military healthcare systems and other federal agencies. This particular order for methylphenidate, a commonly prescribed ADHD medication, exemplifies the routine pharmaceutical procurement activities conducted through the DLA's medical supply chain to sustain operational readiness and healthcare delivery across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/11/25 |